[
    "\n<p><em><u>Reagents setup</u></em></p><p><em>1) Reagents stock</em></p><p>1.1) Y-27632 (ROCK Inhibitor)</p><p>Reconstitute 5 mg in 2.96 mL of sterile water to make a 5 mM stock solution.</p><p>Store at -20 °C for up to 1 year. Avoid multiple freeze-thaw cycles.</p><p><br></p><p>1.2) SB431542 (Activin/BMP/TGF-β pathway inhibitor)</p><p>Reconstitute 10 mg in 2.6 mL of DMSO to make a 10 mM stock solution.</p><p>Store at -20 °C for up to 1 year. Avoid multiple freeze-thaw cycles.</p><p><br></p><p>1.3) IWR1 (WNT Inhibitor)</p><p>Reconstitute 10 mg in 814 μl of DMSO to make a 30 mM stock solution.</p><p>Store at -20 °C for up to 1 year. Avoid multiple freeze-thaw cycles.</p><p><br></p><p>1.4) Heparin</p><p>The concentration used here is measured in mg/ml, however the manufacturer reports quantity in units. The potency (units/mg) is lot-specific; the value can be found on the certificate of analysis (it is typically over 140 units per mg). The number of mg required is calculated by dividing the number of units of the batch by the potency in units per mg. Reconstitute the batch in the volume of water needed to make a 10 mg/mL stock solution. Reconstituted solutions can be stored at 2-8°C for up to 2 years, if sterile filtered through a 0.22 μm filter.</p><p><br></p><p><br></p><p><em>2) Media preparation</em></p><p><br></p><p><em>2.1) Cortical Differentiation Medium I - CDM I [Day 0-18] (quantity per 100 mL medium)</em></p><p>Glasgow MEM, G-MEM (77 mL)</p><p>KnockOut Serum Replacement (20 mL - final 20%)</p><p>MEM Non-Essential Amino Acids Solution (1 mL)</p><p>Sodium pyruvate (1 mL)</p><p>2-mercaptoethanol (182 μL of 55 mM stock - final 0.1 mM)</p><p>Penicillin/Streptomycin Solution (1 mL)</p><p><br></p><p><em>2.2) Cortical Differentiation Medium II - CDM II [Day 18-35] (quantity per 100 mL medium)</em></p><p>DMEM/F-12 (96 mL)</p><p>GlutaMAX Supplement (1 mL)</p><p>N-2 Supplement (1 mL)</p><p>Chemically Defined Lipid Concentrate (1 mL)</p><p>Fungizone (100 μL of 250 μg/ml stock - final 0.25 μg/mL)</p><p>Penicillin/Streptomycin Solution (1 mL)</p><p><br></p><p><em>2.3) Cortical Differentiation Medium III - CDM III [Day 35-70] (quantity per ~200 mL medium)</em></p><p>DMEM/F-12 (170 mL)</p><p>Hyclone Fetal Bovine Serum (20 mL - final 10%)</p><p>Chemically Defined Lipid Concentrate (2 mL)</p><p>GlutaMAX Supplement (2 mL)</p><p>N-2 Supplement (2 mL)</p><p>Heparin (100uL of 10mg/mL - final 5 μg/mL)</p><p>Fungizone (200 μL of 250 μg/mL stock - final 0.25 μg/mL)</p><p>Penicillin/Streptomycin Solution (2 mL)</p><p>Matrigel (2 mL - final 1%)</p><p><br></p><p><em>2.4) Cortical Differentiation Medium IV - CDM IV [Day 70 on] (quantity per ~200 mL medium)</em></p><p>DMEM/F-12 (166 mL)</p><p>Hyclone Fetal Bovine Serum (20 mL - final 10%)</p><p>Chemically Defined Lipid Concentrate (2 mL)</p><p>GlutaMAX Supplement (2 mL)</p><p>N-2 Supplement (2 mL)</p><p>B-27 Supplement (4 mL)</p><p>Heparin (100uL of 10mg/mL stock - 5 μg/mL)</p><p>Fungizone (200 μL of 250 μg/L stock - final 0.25 μg/mL)</p><p>Penicillin/Streptomycin Solution (2 mL)</p><p>Matrigel (4 mL - final 2%)</p><p><br></p><p><br></p><p><em><u>Generation of reproducible human brain organoids</u></em></p><p><br></p><p><em>Maintenance of human pluripotent stem cells (hPSCs)</em></p><p>Maintain feeder-free hPSCs on TC-treated cell culture dishes pre-coated with Geltrex, in mTESR1 medium with 100 U/mL penicillin and 100 μg/mL streptomycin, in a humidified incubator at 37˚C and 5% CO<sub>2</sub>.</p><p><br></p><p>Detailed protocol for thawing, maintenance, and passaging of hPSCs can be found in Arlotta <em>et al.</em>, 2017<sup>[5]</sup>.</p><p><br></p><p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CRITICAL STEP: It is recommended to routinely confirm karyotype stability (suggested: every 5 passages) and make sure that stem cells are mycoplasma-free (on a weekly basis). MycoAlert PLUS Mycoplasma Detection Kit can be used to detect mycoplasma contamination. Single-cell dissociation should be avoided during passaging. The use of non-enzymatic methods to detach cell clumps, for instance Gentle Cell Dissociation Reagent, is recommended.</p><p>&nbsp;</p><p><strong>Day 0 - </strong><em>Cell aggregate formation in CDM I Media</em></p><p>1.&nbsp;&nbsp;&nbsp;Start with hPSCs&nbsp;that are 80-90% confluent.</p><p><br></p><p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CRITICAL STEP: For the generation of brain organoids, it is recommended to use healthy viable hPSCs (mycoplasma-free, karyotypically normal and below passage",
    {
        "title": "50)",
        "body": "with typical morphological features of pluripotent cells (tightly packed colonies of round cells with large nuclei and nucleoli), with no sign of differentiation. Optimal stem cell culture practice and attention to details are essential requirements for the formation of healthy dorsal forebrain organoids.</p><p><br></p><p>2.  Before starting cell dissociation, prepare the following mix <em>(Seeding Medium)</em>:</p><p>-    CDM I (10 mL)</p><p>-     ROCK inhibitor<sup>[6]</sup> (40 μL of 5 mM stock - final 20 μM)</p><p>-     IWR1 (1 μL of 30 mM stock - 3 μM)</p><p>-     SB 431542 (5 μL of 10 mM stock – final 5 μM - final 5 μM)</p><p>3.   Wash the cells with PBS.</p><p>4.  Add Accutase to the dish and incubate for approximately 4-5 minutes at 37˚C.</p><p><br></p><p>·     CRITICAL STEP: Different incubation times may be required depending on cell confluence or for different hPSCs.</p><p><br></p><p>5.   Use a 1 mL pipette to dissociate the cells.</p><p><br></p><p>·     CRITICAL STEP: Avoid rough pipetting to prevent damage to cells, which can lead to cell death.</p><p><br></p><p>6.   Add mTESR1 to dilute the Accutase suspension containing the dissociated cells and transfer content to a 15 mL conical tube.</p><p>7.   Centrifuge the cells.</p><p>8.   Aspirate the supernatant and resuspend the cells in <em>CDM I</em>.</p><p>9.   Centrifuge the cells.</p><p>10. Aspirate the supernatant and resuspend the cells in 1mL of <em>CDM I</em>.</p><p>11. Count the cells.</p><p>12. Dilute the proper volume of cell suspension (containing 900,000 cells) from <em>Step 10 </em>into 10 mL of <em>Seeding Medium. </em></p><p>13. Plate 9,000 cells/well<strong> </strong>in a Prime surface 96V plate (100 μL/well).</p><p>14. Keep the plate in a humidified tissue culture incubator at 37 °C and 5% CO<sub>2</sub>.</p><p><br></p><p><strong>Day 1 – </strong><em>Observe the 96 multiwell plate under the microscope to confirm aggregate formation.</em></p><p><br></p><p>·     CRITICAL STEP: Aggregates with defined and homogeneous borders should be visible, although a few dead cells might appear around the EB (Fig. 1).</p><p><br></p><p><strong>Day 3 - </strong><em>Media change with CDM I Media</em></p><p>15.   Observe the aggregates under the microscope.</p><p>16.   Prepare the following mix:</p><p>-      CDM I (10 mL)</p><p>-      ROCK inhibitor (40 μL of 5 mM stock - final 20 μM)</p><p>-      IWR1 (1 μL of 30 mM stock - final 3 μM)</p><p>-      SB 431542 (5 μL of 10 mM stock - final 5 μM)</p><p>17.   Using a multichannel pipette, add 100 μL of mix to each well.</p><p><br></p><p>·     CRITICAL STEP: before adding fresh medium, gently agitate the medium inside each well by using a multi-channel pipette. This step helps detach dead cells that might surround the aggregate as a result of the dissociation step.</p><p><br></p><p>18. Return the plate to a humidified tissue culture incubator at 37 °C and 5% CO<sub>2</sub>.</p><p><strong> </strong></p><p><strong>Day 6 - </strong><em>Media change with CDM I Media</em></p><p>19.   Prepare the following mix:</p><p>-   CDM I (10 mL)</p><p>-   IWR1 (1 μL of 30 of mM stock - final 3 μM)</p><p>-   SB 431542 (5 μL of 10 mM stock – final 5 μM)</p><p>20.   Remove 80 μL of medium from each well of the multiwell plate.</p><p>21.   Add 100 μL of the mix to each well.</p><p>22. Return the plate to a humidified tissue culture incubator at 37 °C and 5% CO<sub>2</sub>.</p><p>         </p><p><strong>Day 9 - </strong><em>Media change with CDM I Media</em></p><p>23.   Repeat procedure as in Day 6.</p><p> </p><p><strong>Day 12 - </strong><em>Media change with CDM I Media</em></p><p>24.   Repeat procedure as in Day 6.</p><p><br></p><p><strong>Day 15 - </strong><em>Media change with CDM I Media</em></p><p>25.   Repeat procedure as in Day 6.</p><p><br></p><p><strong>Day 18 - </strong><em>Transfer aggregates to 100 mm ultra-low attachment dish filled with CDM II Media</em></p><p>26. Add <em>CDM II</em> to low ultra-low attachment 100 mm plates.</p><p>27. Using a 200 μL pipette transfer aggregates to the 100 mm plate.</p><p>28.  Maintain the plate on a CO<sub>2</sub>-resistant orbital shaker at 70 rpm inside a humidified tissue culture incubator at 37 °C and 5% CO<sub>2</sub>.</p><p><br></p><p><strong>Day 21 - </strong><em>Media change with CDM II Media</em></p><p>29. Aspirate medium in each plate and replace it with <em>CDM II.</em></p><p><br></p><p>·     CRITICAL STEP: Carefully aspirate medium without disturbing the aggregates. A small amount of medium can be left to prevent the aggregates from drying out.</p><p><br></p><p>30.  Return the plate to the orbital shaker at 70 rpm inside a humidified tissue culture incubator at 37 °C and 5% CO2.</p><p><br></p><p><strong>Day 24 - </strong><em>Media change with CDM II Media</em></p><p>31.   Repeat procedure as in Day 21.</p><p><br></p><p><strong>Day 27 - </strong><em>Media change with CDM II Media</em></p><p>32.   Repeat procedure as in Day 21.</p><p><br></p><p><strong>Day 30 - </strong><em>Media change with CDM II Media</em></p><p>33.   Repeat procedure as in Day 21.</p><p><br></p><p><strong>Day 33 - </strong><em>Media change with CDM II Media</em></p><p>34.   Repeat procedure as in Day 21.</p><p><br></p><p><strong>Day 35 - </strong><em>Transfer to spinner flask in CDM III Media</em></p><p>35.   Unpack a spinner flask in a sterile environment and fill it with 100 mL of fresh <em>CDM III Media. </em></p><p>36.  Transfer the aggregates to the spinner flask. Maintain cultures on a magnetic stirrer at 56 rpm (note change in speed) inside a humidified tissue culture incubator at 37 °C and 5% CO<sub>2</sub>.</p><p><br></p><p>·     CRITICAL STEP: Verify that organoids contain dorsal forebrain cell types via immunohistochemistry (IHC) (see Troubleshooting).</p><p><strong> </strong></p><p><strong>Days 42 - </strong><em>Media change with CDM III</em></p><p>37.   Replace the medium by completely aspirating it and adding fresh CDM III.</p><p><br></p><p>·     CRITICAL STEP: To change medium, remove the cap from one of the arms of the spinner flask to insert the 1 mL aspirating pipette; avoid removing the main top cap of the spinner flask, to reduce the chance of contamination.</p><p><br></p><p>38.  Return spinner flasks to a magnetic stirrer at 56 rpm inside a humidified tissue culture incubator at 37 °C and 5% CO2.</p><p><br></p><p><strong>Days 49 - </strong><em>Media change with CDM III</em></p><p>39.   Repeat procedure as in Day 42.</p><p><br></p><p><strong>Days 56 - </strong><em>Media change with CDM III</em></p><p>40.   Repeat procedure as in Day 42.</p><p><br></p><p><strong>Days 63 - </strong><em>Media change with CDM III</em></p><p>41.   Repeat procedure as in Day 42.</p><p><br></p><p><strong>Day 70 and on -</strong><em> Media change with CDM IV</em></p><p>42.  From Day 70 onwards, use the same procedure for changing media, but substitute CDM III with CDM IV.</p><p>43. Maintain spinner flasks on a magnetic stirrer at 56 rpm inside a humidified tissue culture incubator at 37 °C and 5% CO2.</p><p><br></p><p><br></p><p><em><u>Single-cell dissociation of brain organoids for single-cell RNA Sequencing (10x Genomics Chromium platform)</u></em></p><p><br></p><p>The following protocol is a modification of the Worthington Papain Dissociation kit manufacturer's protocol, as used in previous works from our lab <sup>[3,8]</sup>.</p><p><br></p><p>1. Before starting the protocol, reconstitute the following reagents:</p><p>1a. Add 5 mL of Earle’s medium into Papain vial (5 ea/kit - use 1 vial for 2 organoids);</p><p>1b. Add 500 μL of Earle’s medium into DNase vial (5 ea/kit - use 1 vial for 2 organoids);</p><p>1c. Add 32 mL of Earle’s medium into Inhibitor vial (1 ea/kit - use 1 vial for up to 10 organoids).</p><p><br></p><p>2. Mix 500 μL of reconstituted DNase with 5 mL of reconstituted Papain.</p><p><br></p><p>·     CRITICAL STEP: Mix gently as DNase is sensitive to shear denaturation.</p><p><br></p><p>3. Gently transfer each organoid to an individual 60 mm dish.</p><p><br></p><p>4. Carefully aspirate excess media and add 2.5 mL of Papain + DNase solution to the 60 mm dish.</p><p><br></p><p>5. Using a new, sterile razor blade, mince organoids into small pieces (< 1 mm).</p><p><br></p><p>6. Transfer the plate to an orbital shaker at 70 rpm inside a humidified tissue culture incubator at 37 °C and 5% CO<sub>2</sub> for 30 minutes.</p><p><br></p><p>7. Use a 1 mL pipette to gently dissociate and break up minced pieces.</p><p><br></p><p>8. Return the plate to the orbital shaker using the same conditions as <em>Step 6</em> for 10 more minutes.</p><p><br></p><p>9. During this time, add 5 mL of Earle’s medium plus 3 mL of reconstituted Inhibitor solution to a 15 mL conical tube (prepare 1 tube per organoid).</p><p><br></p><p>10. Using a 10 mL pipette, gently pipette the minced pieces up-and-down 10 times.</p><p><br></p><p>11. Transfer the entire volume to an empty 15 mL conical tube and wait for the debris to settle (1-3 minutes).</p><p><br></p><p>12. Transfer the cell suspension (avoiding debris) to the tube prepared in <em>Step 9</em>.</p><p><br></p><p>13. Invert the tube a few times to mix.</p><p><br></p><p>14. Centrifuge the cells at 300<em>g</em> for 7 minutes.</p><p><br></p><p>15. Aspirate the supernatant, and gently resuspend the cells in 500-1,000 μL of 1x PBS.</p><p><br></p><p>16. Filter the resuspended cells.</p><p><br></p><p>17. Dilute and count the cells.</p><p><br></p><p>18. Resuspend the cells at 1,000 cells/μL.</p><p><br></p><p>19. Add BSA to a final concentration of 0.04%.</p>"
    }
]